GENEVA, June 10 -- INTRACT PHARMA LTD (The London BioScience Innovation Centre2 Royal College StreetLondon NW1 0NH) filed a patent application (PCT/EP2024/083901) for "TRANSCYTOSING COMPOSITION" on Nov 28, 2024. With publication no. WO/2025/114429, the details related to the patent application was published on Jun 05, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): KLEIJNEN, Maurits (The London BioScience Innovation Centre2 Royal College StreetLondon NW1 0NH)
Abstract:
The present invention relates to transporter proteins capable of transcytosing the intestinal wall and delivering antibod...